Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

192 trials

NCT06136767
Recruiting
Registry for Systemic Eczema Treatments
Not applicable · United States · 1 site
Registry update: 7 Apr 2026
NCT06238765
Recruiting
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Not applicable · United States · 1 site
Registry update: 29 Jun 2026
NCT06192563
Recruiting
A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment
Not applicable · Italy · 9 sites
Registry update: 13 Aug 2026
NCT05994976
Recruiting
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Not applicable · Canada · 1 site
Registry update: 28 Oct 2026
NCT06882148
Recruiting
Drug Survival of Target Therapies in Atopic Dermatitis
Not applicable · Italy · 1 site
Registry update: 18 Mar 2025
NCT07316465
Recruiting
Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis
Not applicable · Belgium · 1 site
Registry update: 5 Jan 2026
2023-506165-62-00
Recruiting
Optimization of atopic dermatitis treatment that requires second-line systemic therapy through multiomic predictive models of treatment response (DermAtOmics-II)
Phase 4 · Spain · 1 site
Registry update: 20 Aug 2025
NCT06259669
Recruiting
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Not applicable · United States · 1 site
Registry update: 11 Dec 2025
NCT05721937
Recruiting
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Not applicable · United States · 1 site
Registry update: 9 Dec 2025
2024-511390-30-00
Recruiting
Clinical study to compare two cutaneous creams with the active substance methylprednisolone aceponate 0.1% and one cutaneous cream without active substance for patients with atopic dermatitis
Phase 3 · Germany · 9 sites
Registry update: 26 Oct 2026
NCT06390696
Recruiting
Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
Not applicable · Finland · 2 sites
Registry update: 30 Apr 2024
NCT05928169
Recruiting
Determinants of Chronic Inflammatory Skin Disease Trajectories
Not applicable · Germany · 1 site
Registry update: 28 Aug 2026
NCT06055361
Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Phase 1 · United States · 3 sites
Registry update: 19 Sept 2025
NCT06627335
Recruiting
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
Not applicable · United States · 1 site
Registry update: 11 Dec 2025
NCT05758532
Recruiting
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
Phase 4 · Switzerland · 1 site
Registry update: 29 May 2024
NCT05790330
Recruiting
Mind and Skin - the Neurocutaneous Axis in Atopic Eczema
Not applicable · United Kingdom · 1 site
Registry update: 3 May 2024
NCT05689151
Recruiting
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Not applicable · France · 30 sites
Registry update: 7 Jul 2026
NCT05858619
Recruiting
Molecular Signatures of Cutaneous Dupilumab Response
Phase 4 · United States · 1 site
Registry update: 4 Jun 2026
NCT06989216
Recruiting
Multi-modal Quantitative Imaging of the Skin
Not applicable · Sweden · 3 sites
Registry update: 25 May 2025
NCT05268107
Recruiting
Ethnic Differences in Mechanisms of Action of Dupilumab
Phase 4 · United States · 1 site
Registry update: 6 Nov 2025

Ordered by registry start date. Freshness and sponsorship never change the order.